Cargando…

The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection

BACKGROUND: Postoperative lymphocyte to monocyte ratio (post-LMR) change (LMRc) reflects the dynamic change of balance between inflammatory reaction and immune reaction after curative operation. An elevated preoperative LMR (pre-LMR) has been shown to be a prognostic factor in patients with esophage...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Qian, Wu, Jun-zhou, Jiang, Hui-fen, Wang, Sheng, Cai, Shu-nv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193282/
https://www.ncbi.nlm.nih.gov/pubmed/32377268
http://dx.doi.org/10.1155/2020/1451864
_version_ 1783528164526391296
author Song, Qian
Wu, Jun-zhou
Jiang, Hui-fen
Wang, Sheng
Cai, Shu-nv
author_facet Song, Qian
Wu, Jun-zhou
Jiang, Hui-fen
Wang, Sheng
Cai, Shu-nv
author_sort Song, Qian
collection PubMed
description BACKGROUND: Postoperative lymphocyte to monocyte ratio (post-LMR) change (LMRc) reflects the dynamic change of balance between inflammatory reaction and immune reaction after curative operation. An elevated preoperative LMR (pre-LMR) has been shown to be a prognostic factor in patients with esophageal squamous cell carcinoma (ESCC), but the clinical value of the LMRc remains unknown. METHODS: 674 patients in ESCC undergoing curative operation were enrolled in this study. LMRc (LMRc = pre‐LMR–post‐LMR) was counted on the basis of data within one week before and after operation. The median of LMRc was chosen to be the optimal cut-off value to evaluate the prognostic value of LMRc. RESULTS: Kaplan-Meier curves revealed that LMRc ≤ 1.59 was significantly associated with worse overall survival (OS) (P = 0.003) and disease-free survival (DFS) (P = 0.008). Multivariate analysis suggested that LMRc could serve as an independent prognostic predictor for both OS (P = 0.006, HR = 0.687, 95% CI 0.526-0.898) and DFS (P = 0.003, HR = 0.640, 95% CI 0.476-0.859). CONCLUSIONS: LMRc is a promising prognostic predictor for predicting the worse clinical outcome in patients with ESCC undergoing curative operation.
format Online
Article
Text
id pubmed-7193282
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-71932822020-05-06 The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection Song, Qian Wu, Jun-zhou Jiang, Hui-fen Wang, Sheng Cai, Shu-nv Dis Markers Research Article BACKGROUND: Postoperative lymphocyte to monocyte ratio (post-LMR) change (LMRc) reflects the dynamic change of balance between inflammatory reaction and immune reaction after curative operation. An elevated preoperative LMR (pre-LMR) has been shown to be a prognostic factor in patients with esophageal squamous cell carcinoma (ESCC), but the clinical value of the LMRc remains unknown. METHODS: 674 patients in ESCC undergoing curative operation were enrolled in this study. LMRc (LMRc = pre‐LMR–post‐LMR) was counted on the basis of data within one week before and after operation. The median of LMRc was chosen to be the optimal cut-off value to evaluate the prognostic value of LMRc. RESULTS: Kaplan-Meier curves revealed that LMRc ≤ 1.59 was significantly associated with worse overall survival (OS) (P = 0.003) and disease-free survival (DFS) (P = 0.008). Multivariate analysis suggested that LMRc could serve as an independent prognostic predictor for both OS (P = 0.006, HR = 0.687, 95% CI 0.526-0.898) and DFS (P = 0.003, HR = 0.640, 95% CI 0.476-0.859). CONCLUSIONS: LMRc is a promising prognostic predictor for predicting the worse clinical outcome in patients with ESCC undergoing curative operation. Hindawi 2020-04-22 /pmc/articles/PMC7193282/ /pubmed/32377268 http://dx.doi.org/10.1155/2020/1451864 Text en Copyright © 2020 Qian Song et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Song, Qian
Wu, Jun-zhou
Jiang, Hui-fen
Wang, Sheng
Cai, Shu-nv
The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection
title The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection
title_full The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection
title_fullStr The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection
title_full_unstemmed The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection
title_short The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection
title_sort postoperative lymphocyte to monocyte ratio change predicts poor clinical outcome in patients with esophageal squamous cell carcinoma undergoing curative resection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193282/
https://www.ncbi.nlm.nih.gov/pubmed/32377268
http://dx.doi.org/10.1155/2020/1451864
work_keys_str_mv AT songqian thepostoperativelymphocytetomonocyteratiochangepredictspoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinomaundergoingcurativeresection
AT wujunzhou thepostoperativelymphocytetomonocyteratiochangepredictspoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinomaundergoingcurativeresection
AT jianghuifen thepostoperativelymphocytetomonocyteratiochangepredictspoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinomaundergoingcurativeresection
AT wangsheng thepostoperativelymphocytetomonocyteratiochangepredictspoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinomaundergoingcurativeresection
AT caishunv thepostoperativelymphocytetomonocyteratiochangepredictspoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinomaundergoingcurativeresection
AT songqian postoperativelymphocytetomonocyteratiochangepredictspoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinomaundergoingcurativeresection
AT wujunzhou postoperativelymphocytetomonocyteratiochangepredictspoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinomaundergoingcurativeresection
AT jianghuifen postoperativelymphocytetomonocyteratiochangepredictspoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinomaundergoingcurativeresection
AT wangsheng postoperativelymphocytetomonocyteratiochangepredictspoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinomaundergoingcurativeresection
AT caishunv postoperativelymphocytetomonocyteratiochangepredictspoorclinicaloutcomeinpatientswithesophagealsquamouscellcarcinomaundergoingcurativeresection